0001104659-20-104516.txt : 20200911
0001104659-20-104516.hdr.sgml : 20200911
20200911190714
ACCESSION NUMBER: 0001104659-20-104516
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200909
FILED AS OF DATE: 20200911
DATE AS OF CHANGE: 20200911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kleiner Perkins Caufield & Byers XV, LLC
CENTRAL INDEX KEY: 0001547840
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 201171955
BUSINESS ADDRESS:
STREET 1: 2750 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (650) 233-2750
MAIL ADDRESS:
STREET 1: 2750 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KPCB XV Associates, LLC
CENTRAL INDEX KEY: 0001547838
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 201171956
BUSINESS ADDRESS:
STREET 1: 2750 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (650) 233-2750
MAIL ADDRESS:
STREET 1: 2750 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KPCB XV Founders Fund, LLC
CENTRAL INDEX KEY: 0001547839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 201171957
BUSINESS ADDRESS:
STREET 1: 2750 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (650) 233-2750
MAIL ADDRESS:
STREET 1: 2750 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
tm2030740d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-09-09
0
0001673772
RAPT Therapeutics, Inc.
RAPT
0001547840
Kleiner Perkins Caufield & Byers XV, LLC
C/O KLEINER PERKINS CAUFIELD & BYERS
2750 SAND HILL ROAD
MENLO PARK
CA
94025
0
0
1
0
0001547838
KPCB XV Associates, LLC
C/O KLEINER PERKINS CAUFIELD & BYERS
2750 SAND HILL ROAD
MENLO PARK
CA
94025
0
0
1
0
0001547839
KPCB XV Founders Fund, LLC
C/O KLEINER PERKINS CAUFIELD & BYERS
2750 SAND HILL ROAD
MENLO PARK
CA
94025
0
0
1
0
Common Stock
2020-09-09
4
J
0
650000
0
D
2597063
I
By KPCB Holdings, Inc., as nominee
Kleiner Perkins Caufield & Byers XV, LLC ("KPCB XV") made a pro rata distribution for no consideration to its members of 631,150 shares of common stock on September 9, 2020. KPCB XV Founders Fund, LLC ("KPCB XV FF") made a pro rata distribution for no consideration to its members of 18,850 shares of common stock on September 9, 2020.
The shares are held for convenience in the name of KPCB Holdings, Inc., as nominee for the accounts of the following entities as follows: 2,521,749 shares held for the account of KPCB XV and 75,314 shares held for the account of KPCB XV FF. The managing member of KPCB XV and KPCB XV FF is KPCB XV Associates, LLC ("KPCB XV Associates"). Beth Seidenberg, L. John Doerr, Randy Komisar, Theodore E. Schlein, Wen Hsieh and William "Bing" Gordon, the managing members of KPCB XV Associates, exercise shared voting and dispositive control over the shares held by KPCB Holdings, Inc. as nominee for the accounts of KPCB XV and KPCB XV FF. KPCB XV Associates and each of its managing members disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that KPCB XV Associates or any of its managing members is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
/s/ Susan Biglieri, Chief Financial Officer
2020-09-11